Global Wholehealth Partners Corp. (GWHP)

[dailystockexpert]

New Research - Goldman Small Cap Research on Global WholeHealth Partners Corporation

GWHP is set to emerge as a key provider of COVID-19 diagnostics test kits, a multi-billion-dollar market. As part of the steps to reach this objective, the Company offers all of the formats for COVID-19 testing.

GWHP has filed an Emergency Use Application (EUA) with the FDA for its rapid anti-body test with response pending. In studies performed in 2020, GWHP's diagnostic test produced an accuracy rate of over 97%, prompting the Department of the Navy to place an order for 1000 kits.

In the Opportunity Research update, analyst Rob Goldman discusses the recent company events and the potential resultant impact on the Company.